1. Home
  2. IMAB vs CRNT Comparison

IMAB vs CRNT Comparison

Compare IMAB & CRNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMAB
  • CRNT
  • Stock Information
  • Founded
  • IMAB 2014
  • CRNT 1996
  • Country
  • IMAB United States
  • CRNT Israel
  • Employees
  • IMAB N/A
  • CRNT N/A
  • Industry
  • IMAB Biotechnology: Pharmaceutical Preparations
  • CRNT Radio And Television Broadcasting And Communications Equipment
  • Sector
  • IMAB Health Care
  • CRNT Technology
  • Exchange
  • IMAB Nasdaq
  • CRNT Nasdaq
  • Market Cap
  • IMAB 200.9M
  • CRNT 218.8M
  • IPO Year
  • IMAB 2020
  • CRNT 2000
  • Fundamental
  • Price
  • IMAB $2.11
  • CRNT $2.29
  • Analyst Decision
  • IMAB Strong Buy
  • CRNT Strong Buy
  • Analyst Count
  • IMAB 3
  • CRNT 5
  • Target Price
  • IMAB $6.33
  • CRNT $5.75
  • AVG Volume (30 Days)
  • IMAB 392.1K
  • CRNT 823.8K
  • Earning Date
  • IMAB 05-15-2025
  • CRNT 08-06-2025
  • Dividend Yield
  • IMAB N/A
  • CRNT N/A
  • EPS Growth
  • IMAB N/A
  • CRNT 367.84
  • EPS
  • IMAB N/A
  • CRNT 0.25
  • Revenue
  • IMAB N/A
  • CRNT $394,344,000.00
  • Revenue This Year
  • IMAB N/A
  • CRNT $3.12
  • Revenue Next Year
  • IMAB N/A
  • CRNT $7.89
  • P/E Ratio
  • IMAB N/A
  • CRNT $9.00
  • Revenue Growth
  • IMAB N/A
  • CRNT 11.94
  • 52 Week Low
  • IMAB $0.60
  • CRNT $1.95
  • 52 Week High
  • IMAB $3.08
  • CRNT $5.73
  • Technical
  • Relative Strength Index (RSI)
  • IMAB 49.47
  • CRNT 43.34
  • Support Level
  • IMAB $2.01
  • CRNT $2.21
  • Resistance Level
  • IMAB $2.25
  • CRNT $2.41
  • Average True Range (ATR)
  • IMAB 0.13
  • CRNT 0.09
  • MACD
  • IMAB -0.03
  • CRNT -0.02
  • Stochastic Oscillator
  • IMAB 25.00
  • CRNT 18.60

About IMAB I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

About CRNT Ceragon Networks Ltd.

Ceragon Networks Ltd is a wireless transport company in terms of unit shipments and wide distribution of its business, providing high-capacity wireless connectivity solutions to markets across various industries, mainly wireless (mobile) networks service providers. Geographically the company generates the key revenue from India. The company also has presence in North America, Europe, Africa, Asia-Pacific and Middle East, and Latin America. The company's products include IP-50 Platform, IP-20 Platform, Pointlink.

Share on Social Networks: